The opened lower with the Dow losing 23 points to 22,095 as crude oil prices slipped. Nasdaq fell 10 points to 6,373.
On the upside
Michael Kors (NYSE: KORS) reported better than expected earnings and revenue for the first quarter.
FibroGen (Nasdaq: FGEN) reported positive results from a Phase 2 study of pamrevlumab in patients with idiopathic pulmonary fibrosis
Valeant Pharmaceuticals (NYSE: VRX) narrowed losses for the second quarter.
On the downside
DepoMed (Nasdaq: DEPO) widened losses for the second quarter as revenue fell and lowered its full year forecast.
Second quarter earnings plunged for Dean Foods (NYSE: DF).
Plains All American Pipeline (NYSE: PAA) reported second quarter earnings and revenue that missed expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 4 to 3 on the NYSE and by a margin of 5 to 4 on Nasdaq. The broader S&P 500 slipped 2 points to 2,478. Bitcoin rose $9 to $2963.
